What is the recommended post‑exposure prophylaxis after a percutaneous or mucosal blood exposure, including management for HIV, hepatitis B, hepatitis C, and tetanus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Post-Exposure Prophylaxis for Blood Exposure

Immediately wash wounds with soap and water or flush mucous membranes with water, then rapidly test the source patient for HBsAg, anti-HCV, and HIV antibody (using rapid testing when available), and initiate pathogen-specific prophylaxis within hours based on exposure risk and the exposed person's immune status. 1

Immediate Wound Care

First-line management requires:

  • Wash wounds and skin with soap and water
  • Flush mucous membranes with water
  • Do NOT squeeze or manipulate the wound 1

Risk Assessment Framework

Evaluate two critical factors:

Type of fluid:

  • Blood or visibly bloody fluid (highest risk)
  • Other potentially infectious fluids or tissue
  • Concentrated virus

Type of exposure:

  • Percutaneous injury (needlestick, cut)
  • Mucous membrane exposure
  • Nonintact skin exposure
  • Bites resulting in blood exposure 1

Source Patient Testing

Test the source immediately for:

  • HBsAg (Hepatitis B surface antigen)
  • Anti-HCV (Hepatitis C antibody)
  • HIV antibody (consider rapid testing for faster results)

Critical caveat: Do NOT test discarded needles or syringes for virus contamination—this is unreliable and wastes time 1

Pathogen-Specific Prophylaxis

HIV Post-Exposure Prophylaxis

Initiate antiretroviral PEP as soon as possible, ideally within 2 hours and no later than 72 hours after exposure 2, 3

Basic regimen (2001 guidelines):

  • Zidovudine (ZDV/AZT) 600 mg daily in 2-3 divided doses PLUS
  • Lamivudine (3TC) 150 mg twice daily
  • Available as combination product (Combivir) 1

Duration: 28 days (4 weeks) 2, 3

Important considerations:

  • Start with a 5-7 day starter pack if outpatient 2
  • Nevirapine should NEVER be used due to severe hepatic and cutaneous toxicity 2
  • Efavirenz should be avoided if pregnancy is known or suspected due to teratogenicity 2
  • Consultation with infectious disease specialists is strongly recommended for regimen selection 2
  • Reassess within 72 hours for adherence and toxicity 2

Monitoring:

  • Baseline: Complete blood count, renal function, hepatic function, pregnancy test (women)
  • Follow-up labs at 2 weeks: CBC, renal and hepatic function
  • HIV antibody testing: baseline, 6 weeks, 3 months, and 6 months 2, 4

Hepatitis B Post-Exposure Prophylaxis

Management depends entirely on the exposed person's vaccination and immune status:

For unvaccinated persons exposed to HBsAg-positive source:

  • Hepatitis B vaccine series (initiate immediately)
  • PLUS Hepatitis B immune globulin (HBIG) within 24 hours 1, 5

For vaccinated persons with known adequate response (anti-HBs ≥10 mIU/mL):

  • No treatment needed

For vaccinated persons with unknown or inadequate response:

  • Test anti-HBs levels
  • Give HBIG if levels inadequate and source is HBsAg-positive
  • Consider booster dose of vaccine 1

Follow-up testing:

  • Check anti-HBs 1-2 months after last vaccine dose
  • Note: Cannot accurately assess vaccine response if HBIG given within previous 3-4 months 1

Hepatitis C Post-Exposure Management

No prophylaxis is available or recommended for HCV 1, 5

Instead, implement surveillance strategy:

  • Baseline testing: anti-HCV and ALT
  • Follow-up at 4-6 months: anti-HCV and ALT
  • For earlier diagnosis: HCV RNA at 4-6 weeks 1
  • Confirm repeatedly reactive anti-HCV enzyme immunoassays with supplemental tests 1

If acute HCV infection develops:

  • Interferon-alpha monotherapy can prevent chronification in most patients 5
  • Early treatment is key

Tetanus Prophylaxis

Assess tetanus immunization status:

  • If last tetanus toxoid >5 years ago: Give Td (or Tdap if indicated)
  • For contaminated wounds with uncertain/incomplete vaccination: Give tetanus toxoid AND tetanus immune globulin (TIG) 2
  • Use separate syringes and anatomic sites when giving toxoid and TIG concurrently 2

Critical Timing Considerations

Time is tissue—act fast:

  • HIV PEP: Most effective within 2 hours, must start within 72 hours 2, 3
  • Hepatitis B HBIG: Within 24 hours 5
  • Tetanus: Can be given regardless of delay, but earlier is better 4

Common Pitfalls to Avoid

  1. Don't wait for source patient test results to start PEP—initiate based on risk assessment and adjust later 1
  2. Don't use nevirapine in HIV PEP regimens—serious toxicity risk 2
  3. Don't test discarded needles—unreliable and delays care 1
  4. Don't forget pregnancy testing before efavirenz—teratogenic 2
  5. Don't assume vaccinated = immune for HBV—verify anti-HBs response 1

Baseline Testing of Exposed Person

Before or immediately after starting PEP, obtain:

  • HIV antibody
  • HBsAg and anti-HBs (if HBV vaccination status uncertain)
  • Anti-HCV
  • Complete blood count
  • Renal and hepatic function tests
  • Pregnancy test (women of childbearing age) 2, 4

Special Populations

Pregnancy:

  • Not a contraindication to HBV vaccine, HIV PEP, or tetanus toxoid 2
  • Avoid efavirenz—use alternative antiretrovirals 2
  • Prefer Td over Tdap if last tetanus vaccine >5 years ago 2

Related Questions

What post‑exposure prophylaxis and follow‑up should be given to a healthcare worker who briefly entered a patient’s room, looked into the patient’s mouth, and was exposed for less than ten minutes while the patient was coughing?
What is the recommended post‑exposure prophylaxis for HIV, hepatitis B, rabies, tetanus, pertussis, influenza, and COVID‑19 exposures?
I am a 38-year-old woman who noticed bright red blood on my palm after wiping, with no visible skin break; am I at risk of acquiring a blood‑borne pathogen and need post‑exposure prophylaxis?
Should the nurse receive post‑exposure prophylaxis (PEP) after being spat blood into her mouth despite wearing protective equipment?
Which laboratory tests should be obtained immediately after a potential occupational exposure to bloodborne pathogens such as HIV, hepatitis B, and hepatitis C?
Does a depressed patient with marked psychomotor slowing, mutism, staring, confusion, and recent weight loss meet criteria for catatonia?
What rapid‑acting, titratable sedative agents and dosing protocols should be used for adult trauma patients in the trauma unit, including alternatives for hemodynamic instability or contraindications?
What is the recommended management of disseminated intravascular coagulation (DIC)?
How can I explain clonidine in simple terms to a patient with attention‑deficit/hyperactivity disorder and anxiety who has insomnia and experienced next‑day grogginess with trazodone?
A patient who was seen in the emergency department and is now having a telehealth visit with me as their primary care physician requests a narcotic medication. Can I prescribe a narcotic medication during a telehealth visit?
Should empagliflozin (Jardiance) be held during an active urinary tract infection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.